Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer
By LM Forrest, D. McMillan, C. Mcardle, W. Angerson, D. Dunlop. British Journal of Cancer, 2003
789 citations recorded by the source corpus.
A score based on the combination of the systemic inflammatory response and albumin hazards ratio (HR) 1.70, 95% CI 1.23 – 2.35, P=0.001) was comparable in prognostic value to that based on stage and performance status (HR 1.48, 95% CI 1.12 – 1.95, P=0.006) in patients with inoperable non-small-cell lung cancer. The former is simple to measure and well standardised.
Subfields: Internal Medicine, Oncology
View Paper: https://www.semanticscholar.org/paper/54a446d295c07f933f68ca9e2fe6fcad27858444
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Oncology
Citations in the corpus
- Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. (2010, background): “Prognostic value of the preoperative systemic inflammatory response in resectable non-small-cell lung cancer Although the GPS was initially described in nonresectable non-small-cell lung cancer [28], there has been little work examining the value of the preoperative systemic inflammatory response in”